Related Experiment Videos

Perceptions of cancer patients and their physicians involved in phase I clinical trials

P L Weiden, J W Appelbaum

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|September 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL).

Critical reviews in oncology/hematology·2001

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.

Cancer biotherapy & radiopharmaceuticals·2000

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results.

Cancer biotherapy & radiopharmaceuticals·2000

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2000

Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000

See all related articles